Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Operates as an anti-infective drug development company

Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections.

Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections.

The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA.
Managers
NameAgeSinceTitle
Joseph M. Patti, PhD532012President, CEO & Executive Director
Russell H. Plumb MBA, CPA582012Executive Chairman
Mark P. Colonnese, MBA612015Chief Financial Officer & Executive Vice President
Anna Novotney-Barry-2013Vice President-Clinical Development
John H. Vernachio, PhD-2014Vice President-Preclinical Development
Geoffrey F. Cox, PhD732012Independent Non-Executive Director
Anne M. VanLent692013Lead Independent Non-Executive Director
Michael R. Dougherty592013Independent Non-Executive Director
John P. Richard, MBA592013Independent Non-Executive Director
Armando Anido, MBA592015Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 38,649,237 38,192,309 98.8% 0 0.0% 98.8%
Shareholders
NameEquities%
East Hill Management Co. LLC 3,068,358 7.94%
Krensavage Asset Management LLC 2,836,326 7.34%
SC Fund Management LLC 2,429,864 6.29%
Armistice Capital LLC 1,378,463 3.57%
Renaissance Technologies LLC 1,193,485 3.09%
The Vanguard Group, Inc. 990,809 2.56%
Fidelity Management & Research Co. 980,683 2.54%
BlackRock Fund Advisors 476,751 1.23%
Landon Thomas Clay 413,259 1.07%
Gabelli & Co. Investment Advisers, Inc. 224,477 0.58%
Company contact information
Aviragen Therapeutics, Inc.
2500 Northwinds Parkway
Suite 100
Alpharetta, GA 30009

Phone : +1.678.221.3343
Web : www.aviragen.com
Sector Bio Therapeutic Drugs
© 2017 People , Fundamentals and Ownership